Search Results

Genetown

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPHiA GENETICS announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that processes more than 12 million tests annually, will implement SOPHiA GENETICS’ technology and add MSK-ACCESS® liquid biopsy to its test suite.

November 7, 2023

·

6 min read

Deals

Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics Business

Labcorp and OPKO Health, Inc. announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.

March 28, 2024

·

7 min read

Business

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

BioReference® Health, LLC, a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data for the pharmaceutical and life science industries.

November 28, 2023

·

3 min read

Press Releases

Labcorp Completes Acquisition of Select Assets of BioReference Health’s Diagnostics Business from OPKO Health

September 16, 2024

·

5 min read

Business

OPKO Health Announces Leadership Changes for BioReference Laboratories

OPKO Health, Inc. today announced that Jon R. Cohen, M.D., is retiring from his role as Executive Chairman and Chief Executive Officer of BioReference Laboratories and Senior Vice President and a Director of OPKO.

August 16, 2022

·

3 min read

Pharm Country

BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings

BioReference® Health LLC announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from Roche Diagnostics.

February 9, 2023

·

3 min read

Press Releases

Meet Gaelic Laboratories, your trusted testing and manufacturing partner

11 July 2024: Gaelic Laboratories unveils its new website today, launching an upgraded and expanded laboratory technology base for advanced analytical testing, and a newly re-fitted Beta-Lactam manufacturing facility, using the latest state-of-the art technology.

July 11, 2024

·

2 min read

Deals

US BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime Laboratories

US BioTek Laboratories (“US BioTek”), a Clinical Laboratory Improvement Amendments (CLIA) and CAP accredited laboratory, announces the acquisition of Dallas, TX-based RealTime Laboratories (“RealTime”), a pioneer in the field of mycotoxin testing.

March 19, 2024

·

2 min read

Policy

Association for Diagnostics & Laboratory Medicine (formerly AACC) survey finds that FDA’s final laboratory developed tests rule will impede the fight against the U.S.'s drug epidemic

The Association for Diagnostics & Laboratory Medicine released the results of a survey that ADLM conducted to determine how the Food and Drug Administration’s final laboratory developed tests rule will impact patient access to essential tests.

June 25, 2024

·

4 min read

Press Releases

Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.

Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).

July 1, 2024

·

5 min read